Lamilept (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, which stabilizes the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This decreases neuronal hyperexcitability, helping to prevent seizures and mood swings.

The specific dose of Lamilept is determined by the prescribing clinician based on the individual’s medical condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of lamotrigine in pregnancy and lactation is not fully established. Prescribers weigh potential benefits against risks, and women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To request Lamilept, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lamilept (lamotrigine) differs from many antiepileptics by primarily targeting sodium channels and having a favorable profile for mood stabilization. Compared with agents such as carbamazepine or valproic acid, lamotrigine often has fewer cognitive side effects but may require careful monitoring for skin reactions.

Lamilept should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources to maintain product stability.

Lamilept is taken orally, usually as a tablet or film‑coated tablet, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts or behavior. Immediate medical attention is required if any of these occur.

Lamilept is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions to antiepileptic drugs should avoid it, and it should be used with caution in those with liver or kidney impairment.